- Pharmaceutical companies
- Chiesi Farmaceutici
Chiesi Farmaceutici
Phone: +39 5212791
Type | Società per Azioni, (S.p.A.) (something like a Joint-Stock company) |
---|---|
Industry | Pharmaceuticals |
Founded | 1935 |
Headquarters | Parma, Italy |
Key people | Alberto Chiesi (President) Paolo Chiesi (Vice-president) Ugo Di Francesco (CEO) |
Revenue | €2.229 billion (2020) |
Number of employees | 6389 |
Website | www.chiesi.com |
We want to be recognized as an international group focused on research, able to develop and commercialize innovative therapeutic solutions that improve people's quality of life. We intend to maintain a high quality entrepreneurial team, characterized by a spirit of collaboration and self-confidence. Our goal is to combine commitment to results and integrity, operating with responsibility both from a social and an environmental point of view.
For detailed contact information visit location pages below.
Chiesi Farmaceutici's locations around the world
Europe
North America
South America
Oceania
Clinical Trials sponsored by Chiesi Farmaceutici
-
Chiesi ItaliaAktiv, inte rekryterande
-
Chiesi Farmaceutici S.p.A.RekryteringKronisk obstruktiv lungsjukdomBulgarien, Förenta staterna, Albanien, Argentina, Australien, Österrike, Bosnien och Hercegovina, Chile, Kina, Tjeckien, Georgien, Tyskland, Grekland, Ungern, Israel, Italien, Mexiko, Nederländerna, Nya Zeeland, Nordmakedonien, P... och mer
-
Chiesi Farmaceutici S.p.A.Aktiv, inte rekryterande
-
Chiesi Farmaceutici S.p.A.AvslutadTrombos | KateterocklusionFörenta staterna, Argentina, Belgien, Tjeckien, Polen, Rumänien, Spanien
-
Chiesi Farmaceutici S.p.A.AvslutadAlfa-mannosidosFrankrike
-
Chiesi Farmaceutici S.p.A.AvslutadAkut respiratoriskt distress-syndromFörenta staterna, Italien, Storbritannien
-
Chiesi Farmaceutici S.p.A.Aktiv, inte rekryterandeFabrys sjukdomBelgien, Förenta staterna, Storbritannien, Italien, Tjeckien, Danmark, Norge
-
Chiesi Farmaceutici S.p.A.AvslutadPartiell obstruktion av systemisk till lungartärshunt | Komplett obstruktion av systemisk till lungartärshuntFörenta staterna
-
Chiesi Farmaceutici S.p.A.Avslutad